Abstract 3: Targeting Macrophage Necroptosis for Therapeutic and Diagnostic Interventions to Treat Atherosclerosis
Denuja Karunakaran(The University of Queensland), Katey J. Rayner(University of Ottawa), Liang Guo(CVPath Institute), Ljubica Perisic(Karolinska Institutet), Ulf Hedin(Karolinska Institutet), Frank D. Kolodgie(Howard Hughes Medical Institute), Terrence D. Ruddy(University of Ottawa), Renu Virmani(CVPath Institute), Michèle Geoffrion(University of Ottawa), Wei Gan(Sichuan University), Subash Sad(Institute for Biological Sciences), Lihui Wei(University of Ottawa), Lars Mäegdefessel(Technical University of Munich)
Cited by 1
Related Papers
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
|Nature|2010|4k
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
|Nature Immunology|2009|1.5k
Atherosclerotic Plaque Progression and Vulnerability to Rupture
|Arteriosclerosis Thrombosis and Vascular Biology|2005|1.3k
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
|Science|2010|1.3k
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease
|Circulation|2007|1k